Analysis of CD34 populations in mobilised peripheral blood stem cell harvests and in bone marrow by fluorescent in situ hybridisation for the bcr/abl gene fusion in patients with chronic granulocytic leukaemia

Leukemia

Volumn 13, Issue 6, 1999, Pages 944-949

  Irving, Jae ^a   Lennard, A ^a   Storey, N ^a   Conn, J ^a   Dunn, J ^a   Oliver, K ^a   Proctor, S J ^a   Dickinson, A M ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

CD34 positive cells; Chronic granulocytic leukaemia; Fluorescent in situ hybridisation; Peripheral blood stem cell harvests

Indexed keywords

CD34 ANTIGEN;

ADULT; ARTICLE; BONE MARROW CELL; CHRONIC GRANULOCYTIC LEUKEMIA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FUSION; HUMAN; HUMAN CELL; MALE; PERIPHERAL BLOOD STEM CELL; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL;

EID: 0033046850     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401435     Document Type: Article

References (27)

1. Nowell PC, Hungerford DA. A minute chromosome in human chronic granulocytic leukaemia. Science 1960; 132: 1497-1502.
2. Rowley JD. A new consistent chromosome abnormality in chronic myelogenous leukemia. Nature 1973; 243: 290-293.
3. Deklein A, van Kessel AG, Grosveld G, Bartram CR, Hagemeijer A, Bootsma D, Spurr NK, Heisterkamp N, Groffen J, Stephenson JR. A cellular oncogene is translocated to the Ph chromosome in chronic myelocytic leukemia. Nature 1982; 300: 765-767.
4. Daley GQ, Baltimore D. Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic leukemia specific p210 bcr/abl protein. Proc Natl Acad Sci USA 1988; 85: 9312-9316.
5. Daley GQ, Van Etten RA, Baltimore D. Induction of chronic myelogenous leukemia in mice by the p210 bcr/abl gene of the Philadelphia chromosome. Science 1990; 247: 824-830.
6. Bhatia R, Verfaillie C, Miller JS, McGlave PB. Autologous transplantation therapy for chronic myelogenous leukemia. Blood 1997; 89: 2623-2634.
7. O'Brien S, Goldman J. Current approaches to haemapoietic stem-cell purging in chronic myeloid leukemia. J Clin Oncol 1995; 13: 541-546.
8. Haines ME, Goldman JM, Worsley AM, McCarthy DM, Wyatt SE, Dowding C, Kearney L, Th'ng KH, Wareham NJ, Pollock A, Galvin MC, Samson D, Geary CG, Catovsky D, Galton DAG. Chemotherapy and autografting for chronic granulocytic leukaemia in transformation: probable prolongation of survival for some patients. Br J Haematol 1984; 58: 711-721.
9. Reiffers J, Trouette R, Marit G, Montastruc M, Faberes C, Cony-Makhoul P, David B, Bourdeau MJ, Bilhou-Nabera C, Lacombe F, Fevillatre-Fabre F, Vezon G, Bernard PH, Broustet A. Autologous blood stem cell transplantation for chronic granulocytic leukaemia in transformation: a report of 47 cases. Br J Haematol 1991; 77: 339-345.
10. Hoyle C, Gray R, Goldman J. Autografting for patients with CML in chronic phase: an update. Br J Haematol 1994; 86: 76-81.
11. Reiffers J, Goldman J, Meloni G, Cahn JY, Gratwohl A. Autologous stem cell transplantation in chronic myelogenous leukemia: a retrospective analysis of the European Group for Bone Marrow Transplantation. Bone Marrow Transplant 1994; 14: 407-410.
12. Deisseroth AB, Zu Z, Claxton D, Hanania EG, Fu S, Ellerson D, Goldberg L, Thomas M, Janicek K, Anderson WF, Hester J, Korbling M, Durett A, Moen R, Berenson R, Heimfeld S, Hamer J, Calvert L, Tibbits P, Talpaz M, Kantarjian H, Champlin R, Reading C. Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukaemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 1994; 83: 3068-3076.
13. Barnett MJ, Eaves CJ, Phillips GL, Gascoyne RD, Hogge DE, Horssman DE, Humphries RK, Klingemann HG, Lansdorp PM, Nantel SH, Reece DE, Shepherd JD, Spineli JG, Sutherland HJ, Eaves AC. Autografting with cultured marrow in chronic myelogenous leukemia. Results of a pilot study. Blood 1994; 84: 724-732.
14. Carlo-Stella C, Mangoni L, Almicic C, Caramatti C, Cottafari L, Dotti GP, Rizzoli V. Autologous transplant for chronic myelogenous leukemia using marrow treated ex vivo with mafosfamide. Bone Marrow Transplant 1994; 14: 425-432.
15. McGlave P, Muller J, Muller W, Peny E, Fautsch S, Ramsay NKC, Verfaillie CM, Weisdorf DW. Autologous marrow transplant therapy for CML using marrow treated ex vivo with human recombinant interferon gamma. Blood 1994; 84: 537 (Abstr. S1).
16. Korbling M, Burke P, Braine H, Elfenbein BH, Santos G, Kaiser H. Successful engraftment of blood derived stem cells in chronic myelogenous leukemia. Exp Hematol 1981; 9: 684-690.
17. Carella AM, Frassoni F, Podesta M, Pungolino E, Pollicardo N, Ferrero R, Soracco M. Idarubicin containing regimen and G-CSF are able to recruit a high rate of normal progenitor cells during early hematopoietic recovery in patients with CML. J Hematother 1994; 3: 199-202.
18. Kantarjian HM, Talpaz M, Hester J, Feldman E, Korbling M, Liang J, Rios MB, Smith TL, Calvert L, Deisseroth AB. Collection of peripheral blood diploid cells from chronic myelogenous leukemia patients early in the recovery phase from myelosuppression induced by intensive-dose chemotherapy. J Clin Oncol 1995; 13: 553-559.
19. Chalmers EA, Franklin IM, Kelsey SM, Newland AC, Clark RE, Sproul AM, Crotty G, McCann R. Fielding A, Goldstone AH, Hepplestone A, Watson W, Sharp RA, Tansey P. Treatment of chronic myeloid leukaemia in first chronic phase with idarubicin and cytarabine: mobilization of Philadelphia-negative peripheral blood stem cells. Br J Haematol 1997; 96: 627-634.
20. Hughes TP, Grigg A, Szer J, Ho J, Ma D, Dale BM, Green RM, Norman JE, Sage RE, Herrmann R, Cannell P, Schwarer AP, Taylor K, Atkinson K, Arthur C. Mobilization of predominantly Philadelphia chromosome-negative blood progenitors using cyclophosphamide and rHUG-CSF in early chronic-phase chronic myeloid leukaemia: correlation with Sokal prognostic index and haematological control. Br J Haematol 1997; 96: 635-640.
21. Lennard AL, Storey N, Dickinson AM, Irving JA, Rowe D, Conn JS, Proctor SJ. Collection of Philadelphia negative peripheral blood progenitor cells in unselected patients with chronic granulocytic leukaemia. Leukemia 1998; 12: 746-752.
22. Sokal JE. Prognosis in chronic myeloid leukaemia: biology of the disease versus treatment. Ballières Clin Haematol 1987; 4: 907-929.
23. + cells in peripheral and cord blood by flow cytometry. Exp Haematol 1994; 22: 1003-1010.
24. Cross NCP, Melo JV, Feng L, Goldman JM. An optimised multiplex polymerase chain reaction (PCR) for detection of bcr/abl fusion mRNAs in haematological disorders. Leukemia 1994; 8: 186-189.
25. Talpaz M, Kantarjian H, Liang J, Calvert L, Hamer J, Tibbits P, Durett A, Claxton D, Giralt S, Khouri I, Przepiorka D, Van Besien K, Andersson B, Mehra R, Gajewski J, Seong D, Hester J, Estey E, Korbling M, Pollicardo N, Berenson R, Heimfeld S, Champlin R, Deisseroth AB. Percentage of Philadelphia chromosome (Ph)-negative and Ph-positive cells found after autologous transplantation for chronic myelogenous leukemia depends on percentage of diploid cells induced by conventional dose chemotherapy before collection of autologous cells. Blood 1995; 85: 3257-3263.
26. Talmadge JE. The combination of stem cell transplantation and immunotherapy: future potential. In Vivo 1994; 8: 675-690.
27. Carella AM, Cunningham I, Lerma E, Dejana A, Benvenuto F, Podesta M, Celesti L, Chimirri F, Abate M, Vassallo D, Osvaldo F, Parodi C, Sessarego M, Valbonesi M, Carlier P, Prenipe E, Gatti AM, Van Den Berg D, Hoffman R, Frassoni F. Mobilization and transplantation of Philadelphia-negative peripheral blood progenitor cells early in chronic myelogenous leukemia. J Clin Oncol 1997; 15: 1575-1582.